Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension

BACKGROUND: To evaluate the cost‐effectiveness of combination pulmonary arterial hypertension specific therapy in systemic sclerosis–related PAH. METHODS AND RESULTS: Health outcomes and costs were captured through data linkage. Health utility was derived from Medical Outcomes Study Short Form‐36 sc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Tran‐Duy, An, Morrisroe, Kathleen, Clarke, Philip, Stevens, Wendy, Proudman, Susanna, Sahhar, Joanne, Nikpour, Mandana
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8174376/
https://ncbi.nlm.nih.gov/pubmed/33759539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015816
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars